Stool host transcriptome reveals gut epithelial cell states and immune dynamics for gastrointestinal diagnosis and monitoring
In the authors' words
Gastrointestinal diagnosis and monitoring rely on colonoscopy, which requires anesthesia and a long wait, and non-invasive alternatives are lacking. Here we show that whole-transcriptome sequencing of stool host RNA, recovering a median of 6300 protein-coding genes across 285 libraries spanning colorectal cancer (CRC) and inflammatory bowel disease (IBD), precancerous lesions (APL), and normal samples, reads a census of the cells shed into the lumen. In normal samples, epithelium supplies 81% and immune cells supply 11% of stool host mRNA transcripts; the immune cells' share rises in CRC and IBD, and B- and T-cell receptor clonotypes rise with it. In this work, we show that CRC, IBD, and normal samples carry distinct transcriptome profiles, which a three-class model separates with an area under the curve of 0.94-0.96, and that within inflammatory bowel disease a 15-gene neutrophil score tracks endoscopic activity better than fecal calprotectin in the same stool.
In plain words AI summary
Colonoscopy is the main way to diagnose gut problems, but it needs anesthesia and long waits. The authors sequenced RNA from stool samples to read which cells had shed into the gut. In healthy people, gut lining cells provide 81% of stool RNA and immune cells provide 11%. A 15-gene score tracked bowel disease activity better than the standard calprotectin test.
Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source. 2 sentences were removed for not being supported by the abstract.
Appeared: Tuesday, November 3. medRxiv. Preprint, not yet peer-reviewed.